ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. ProMIS Neurosciences Inc. market cap is $51.16M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. ProMIS Neurosciences Inc. 52 week high is $39.75 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ProMIS Neurosciences Inc. 52 week low is $6.27 as of November 15, 2026.
ProMIS Neurosciences Inc. stock price today is $22.09.
ProMIS Neurosciences Inc. stock price yesterday was $23.77.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. ProMIS Neurosciences Inc.'s P/E ratio is -1.28.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. ProMIS Neurosciences Inc. P/B ratio is 5.5689.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. ProMIS Neurosciences Inc. 50-day moving average is $13.35.
